Why New Fortress Energy Stock Sank Today
The Motley Fool· 2025-05-21 20:37
Shares of New Fortress Energy (NFE -14.54%) fell on Wednesday. The company's stock plummeted 14.5% as of market close. The leg down comes as the S&P 500 (^GSPC -1.61%) and the Nasdaq Composite (^IXIC -1.41%) lost 1.6% and 1.4%, respectively.New Fortress is excluded from Puerto RicoThe liquefied natural gas (LNG) company will not be able to take part in a key government auction in Puerto Rico. It was revealed late yesterday that New Fortress has been disqualified from a Puerto Rican government auction to sec ...
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs
CNBC· 2025-05-21 20:37
Only half of health insurer Cigna's clients currently cover the popular GLP-1 weight loss drugs Wegovy and Zepbound because of their high costs. But the company's pharmacy benefits unit Evernorth has reached a deal with drug makers Ely Lilly and Novo Nordisk which it said will bring prices down for employers and their workers."This solution is really focused towards clients that aren't covering it today, and what it allows us to do is one, to bring it on at a reduced price for the plan sponsor, but also cap ...
What Regeneron's Purchase Of 23andMe Means For Your Genetic Privacy
Forbes· 2025-05-21 20:35
Regeneron buys 23andMe Getty ImagesRegeneron Pharmaceuticals announced on Monday it will acquire bankrupt genomics firm 23andMe for $256 million through a bankruptcy auction, promising to maintain ethical standards in handling sensitive customer DNA information.According to Reuters, the New York-based pharmaceutical giant aims to leverage 23andMe’s extensive database of over 15 million customer DNA samples to enhance its genomic-driven drug discovery processes. The acquisition comes at a crucial time as con ...
A Very Good Month For Boeing
Forbes· 2025-05-21 20:35
Sign with logo at entrance to office of aerospace company Boeing. (Photo by Smith ... More Collection/Gado/Getty Images)Getty ImagesThe past several weeks have been a welcome change for Boeing, which has struggled for the past seven years with fatal crashes, a pandemic travel shutdown, quality and safety incidents halting production and a labor strike that pushed the company to the brink.However, after nine months on the job, CEO Kelly Ortberg’s recovery plan is showing strong progress.On April 22, Boeing a ...
Nike will raise prices on a wide range of products as soon as this week
CNBC· 2025-05-21 20:30
Nike shoes are seen in the King of Prussia Mall, as global markets brace for a hit to trade and growth caused by U.S. President Donald Trump's decision to impose import tariffs on dozens of countries, in King of Prussia, Pennsylvania, U.S., April 3, 2025.Nike will raise prices on a wide range of footwear, apparel and equipment as soon as this week as the retail industry braces for tariffs to hit its profits, CNBC has learned.Prices for Nike apparel and equipment for adults will increase between $2 and $10, ...
Crocs, Inc. Appoints Terence Reilly to Chief Brand Officer Role
Prnewswire· 2025-05-21 20:30
BROOMFIELD, Colo., May 21, 2025 /PRNewswire/ -- Crocs, Inc. (NASDAQ: CROX), a world leader in innovative casual footwear for all, today announced that the organization has elevated Terence Reilly to Executive Vice President, Chief Brand Officer, with oversight over the marketing and communications functions for both the Crocs and HEYDUDE brands, effective immediately.As a veteran brand expert, Terence has a proven track record of building lasting brand identity, connecting to relevant culture and creating s ...
Cellectis' Annual Shareholders General Meeting to be Held on June 26, 2025
GlobeNewswire News Room· 2025-05-21 20:30
NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that it will hold its annual general meeting on June 26, 2025 at 2:30 p.m. CET at the Biopark auditorium, 11 rue Watt, 4th floor, 75013 Paris, France. The notice convening the annual general meeting stating the detailed agenda and modalities of participati ...
Evernorth Launches New Benefit Option That Drives Lower Net Cost for Weight Loss Medicines and Limits Patient Cost to No More Than $200 Per Month
Prnewswire· 2025-05-21 20:30
Patients can save as much as $3600 per year versus direct-to-consumer manufacturer programs, and out of pocket cost applies to their annual deductible New offering helps employers meet growing demand for FDA-approved weight loss medications at a lower net cost per prescription while ensuring clinical safety for patientsST LOUIS, May 21, 2025 /PRNewswire/ -- Evernorth, the health services division of The Cigna Group (NYSE: CI) announced a first-of-its-kind pharmacy benefit offering that make weight loss me ...
Ekso Bionics Announces New Effective Date of Reverse Stock Split
GlobeNewswire News Room· 2025-05-21 20:30
SAN RAFAEL, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (the “Company”) (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced that it has updated the effective date of its reverse stock split of shares of its common stock at a ratio of 1-for-15 to June 2, 2025 at 12:01 a.m., Pacific time, rather than the previously disclosed effective date of May 27, 2025 at 12:01 a.m. Pacific time. The Company’s common stock will open for trading on The ...
Lilly's Kisunla (donanemab) receives marketing authorization in Australia for the treatment of early symptomatic Alzheimer's disease
Prnewswire· 2025-05-21 20:21
The authorization in Australia is for adult patients who are Apolipoprotein E-ε4 heterozygotes or non-carriers INDIANAPOLIS, May 21, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the Australian Therapeutic Goods Administration (TGA) has granted marketing authorization for Kisunla (donanemab), an injection for intravenous infusion every four weeks to treat mild cognitive impairment and mild dementia due to Alzheimer's disease in adults who are Apolipoprotein E ε4 (ApoE ε4) heter ...